| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3353731 | Immunity | 2009 | 5 Pages |
Abstract
Recent studies have provided important insights into the pathogenesis of inflammatory bowel disease (IBD). The development of new therapeutic agents has been triggered by basic research and studies in mouse models of IBD. It is expected that improved translational research will lead to optimized therapy and new individualized treatment options.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Markus F. Neurath, Susetta Finotto,